ID   CSQT-1
AC   CVCL_XE56
DR   CCRID; 4201PAT-CCTCC00241
DR   Wikidata; Q93459689
RX   DOI=10.3724/SP.J.1008.2009.00001;
RX   Patent=CN101597591B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200814.
CC   Population: Chinese.
CC   Doubling time: 48.2 hours (Patent=CN101597591B).
CC   Derived from site: Metastatic; Portal vein; UBERON=UBERON_0002017.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
RX   DOI=10.3724/SP.J.1008.2009.00001;
RA   Hu H.-S., Cheng S.-Q., Shi J., Guo W.-X., Xue J., Li N., Xie D.,
RA   Wu M.-C.;
RT   "Establishment and characterization of a human hepatocellular
RT   carcinoma cell line CSQT-1 derived from portal vein tumor thrombus.";
RL   Di 2 Jun Yi Da Xue Xue Bao 30:1-4(2009).
//
RX   Patent=CN101597591B;
RA   Wu M.-C., Cheng S.-Q., Hu H.-S.;
RT   "Liver cancer cell line from liver cancer portal vein tumor thrombus
RT   of human and line establishing method thereof.";
RL   Patent number CN101597591B, 11-May-2011.
//